Russell Maxwell

1.1k total citations
32 papers, 496 citations indexed

About

Russell Maxwell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Russell Maxwell has authored 32 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Russell Maxwell's work include Glioma Diagnosis and Treatment (9 papers), Brain Metastases and Treatment (6 papers) and CAR-T cell therapy research (5 papers). Russell Maxwell is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Brain Metastases and Treatment (6 papers) and CAR-T cell therapy research (5 papers). Russell Maxwell collaborates with scholars based in United States, Netherlands and Italy. Russell Maxwell's co-authors include Michael Lim, Christopher M. Jackson, Tomás Garzón-Muvdi, Andrew S. Luksik, Eileen Kim, Henry Brem, Zineb Belcaid, Drew M. Pardoll, Debebe Theodros and Yuanxuan Xia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Cancer Research.

In The Last Decade

Russell Maxwell

30 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell Maxwell United States 11 259 191 187 108 81 32 496
Jonathan B. Lamano United States 14 223 0.9× 234 1.2× 258 1.4× 125 1.2× 135 1.7× 23 653
Hilko Ardon Netherlands 14 306 1.2× 346 1.8× 313 1.7× 76 0.7× 111 1.4× 27 636
Jennifer L. Crombie United States 15 421 1.6× 141 0.7× 277 1.5× 71 0.7× 164 2.0× 63 822
Yukina Morimoto Japan 14 126 0.5× 114 0.6× 196 1.0× 67 0.6× 125 1.5× 33 483
Matthew K. Schoen United States 7 127 0.5× 363 1.9× 138 0.7× 44 0.4× 105 1.3× 12 538
Neal Huang United States 5 356 1.4× 280 1.5× 307 1.6× 116 1.1× 200 2.5× 9 671
Zachary R. Barnard United States 11 236 0.9× 111 0.6× 145 0.8× 59 0.5× 132 1.6× 28 559
Mariza Daras United States 13 175 0.7× 55 0.3× 153 0.8× 150 1.4× 168 2.1× 38 479
Ashley Plant United States 11 166 0.6× 193 1.0× 257 1.4× 69 0.6× 130 1.6× 29 550
Lindsey A. Olivere United States 8 200 0.8× 61 0.3× 52 0.3× 79 0.7× 131 1.6× 19 480

Countries citing papers authored by Russell Maxwell

Since Specialization
Citations

This map shows the geographic impact of Russell Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Maxwell more than expected).

Fields of papers citing papers by Russell Maxwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Maxwell. The network helps show where Russell Maxwell may publish in the future.

Co-authorship network of co-authors of Russell Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Maxwell. A scholar is included among the top collaborators of Russell Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Maxwell. Russell Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Aman M., Jake J. Lee, Russell Maxwell, et al.. (2025). Adjuvant radiotherapy in pT3–4N0M0 major salivary gland Cancer without other adverse features. American Journal of Otolaryngology. 46(5). 104628–104628. 1 indexed citations
2.
Patel, Aman M., Russell Maxwell, John N. Lukens, et al.. (2024). Choice of Adjuvant Radiotherapy Facility in Major Salivary Gland Cancer. The Laryngoscope. 134(8). 3620–3632. 9 indexed citations
3.
Lukens, John N., Emily MacDuffie, G S Weinstein, et al.. (2024). Phase II Study of Radiation Volume and Dose De-Intensification Following Tors and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma – Long-Term Results of Expanded Cohort. International Journal of Radiation Oncology*Biology*Physics. 120(2). S121–S121.
4.
Patel, Aman M., Russell Maxwell, Jason A. Brant, et al.. (2024). Choice of Adjuvant Radiotherapy Facility in Sinonasal Squamous Cell Carcinoma. The Laryngoscope. 135(2). 705–715. 2 indexed citations
5.
Patel, Aman M., et al.. (2024). Missed Adjuvant Therapy in Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma. The Laryngoscope. 135(2). 729–740. 3 indexed citations
6.
Barsky, Andrew R., Stefan Both, John P. Christodouleas, et al.. (2023). Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. International Journal of Particle Therapy. 10(1). 1–12. 3 indexed citations
7.
Wright, Christopher M., Jonathan Baron, Russell Maxwell, et al.. (2022). Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?. Advances in Radiation Oncology. 7(6). 101016–101016. 4 indexed citations
8.
Baron, Jonathan, Christopher M. Wright, Russell Maxwell, et al.. (2022). Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration. Advances in Radiation Oncology. 8(1). 101090–101090. 1 indexed citations
9.
Cohen, Adam D., Simon F. Lacey, Megan M. Davis, et al.. (2021). The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma. Clinical Cancer Research. 27(23). 6580–6590. 23 indexed citations
10.
Maxwell, Russell, Emily J. Anstadt, Adam Waxman, et al.. (2021). Radiation Therapy for Plasma Cell Disease of the Brain and Skull: Poor Palliation and Survival After Treatment for Central Nervous System Involvement. Advances in Radiation Oncology. 6(4). 100720–100720. 2 indexed citations
11.
Garzón-Muvdi, Tomás, Russell Maxwell, Andrew S. Luksik, et al.. (2020). Scalp Invasion by Atypical or Anaplastic Meningioma Is a Risk Factor for Development of Systemic Metastasis. World Neurosurgery. 142. e133–e139. 10 indexed citations
12.
Akinbiyi, Takintope, Geoffrey M. Kozak, Arturo J. Rios-Diaz, et al.. (2020). Contemporary treatment of keloids: A 10-year institutional experience with medical management, surgical excision, and radiation therapy. The American Journal of Surgery. 221(4). 689–696. 6 indexed citations
13.
Wu, Adela, Russell Maxwell, Yuanxuan Xia, et al.. (2019). Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment. Journal of Neuro-Oncology. 143(2). 241–249. 103 indexed citations
14.
Deng, Zijian, Tomás Garzón-Muvdi, Yuanxuan Xia, et al.. (2019). In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation. International Journal of Radiation Oncology*Biology*Physics. 106(3). 612–620. 17 indexed citations
15.
Lim, Michael, et al.. (2018). Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cells. Surgical Neurology International. 9(1). 146–146. 6 indexed citations
16.
Maxwell, Russell, Andrew S. Luksik, Tomás Garzón-Muvdi, et al.. (2018). Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma. World Neurosurgery. 119. e1006–e1015. 12 indexed citations
17.
Xia, Yuanxuan, Leila A. Mashouf, Brock R. Baker, et al.. (2018). Outcomes of Metastatic Brain Lesions Treated with Radioactive Cs-131 Seeds after Surgery: Experience from One Institution. Cureus. 10(7). e3075–e3075. 6 indexed citations
18.
Maxwell, Russell, Christopher M. Jackson, & Michael Lim. (2017). Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma. Current Treatment Options in Oncology. 18(8). 51–51. 66 indexed citations
19.
Luksik, Andrew S., Russell Maxwell, Tomás Garzón-Muvdi, & Michael Lim. (2017). The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors. Neurotherapeutics. 14(4). 1049–1065. 21 indexed citations
20.
Maxwell, Russell, Tomás Garzón-Muvdi, Evan J. Lipson, et al.. (2016). BRAF‐V600 mutational status affects recurrence patterns of melanoma brain metastasis. International Journal of Cancer. 140(12). 2716–2727. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026